Research News

Combinational therapeutic strategy for Breast Cancer treatment

Chemotherapy-associated adverse events can result in early termination of cancer treatment. In this article,  A/Prof Franco-Obregon  demonstrates the sensitivity of breast cancer cells to combinational therapy of chemotherapy and pulsed electromagnetic field therapy. The potential value of this unique combination merits future investigation into new therapeutic strategies for breast cancer treatment.

 

Read more: https://doi.org/10.3389/fonc.2021.783803

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera

Muscle is our first line of defence against cancer. A randomised clinical trial in Singapore, led by N2CR members A/Prof …

Read More →
Research News

Efficacy of Combined Pembrolizumab and Bevacizumab in Platinum-Resistant Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is common in South China and parts of Southeast Asia. Despite treatment, 20-30% of patients relapse within …

Read More →
Research News

Cell Cycle Dysregulation in Cancer

A study led by Dr Alan Prem Kumar, a member of N2CR, delves into how cancer arises from disruptions in …

Read More →